Biosimilars Experts 2025

Dr. Sarassawadee Suwanjinda ("Dr. Petch") is Co-Founder and Chief Medical Strategy Officer at Healthi Life, Bangkok's Urban Longevity House. Certifications: - International Board of Lifestyle Medicine (IBLM) - International Society for Stem Cell Application (ISSCA) - Certified Board of Anti-Aging Medicine (CBAM) - American Academy of Aesthetic Medicine (AAAM) - Certificate in Aesthetic Medicine 10+ years of clinical experience in longevity, regenerative, functional, and lifestyle medicine. Available for expert medical commentary on: - Longevity medicine and healthspan extension - Stem cell and exosome therapy safety - NAD+ IV therapy and mitochondrial health - Peptide therapy and physician oversight (Tirzepatide, Retatrutide, BPC-157) - Hormone optimization (testosterone, perimenopause) - 300+ biomarker health check-ups - Functional medicine for chronic conditions Located in Ekkamai, Bangkok. Serving 50+ nationalities.

Imtiaz Ibne Alam, B.Pharm, RPh, is a registered pharmacist and freelance medical writer with 15+ years of experience across healthcare, pharmaceutical writing and scientific communication. He writes and edits peer-reviewed manuscripts, systematic reviews, pharmacovigilance and drug safety documents, regulatory and CMC content and patient education on topics such as diabetes and glucose monitoring. He has supported 20+ indexed publications and is a named co-author in the Journal of Integrative Medicine. He is available to comment on medical writing, publication ethics, drug safety, evidence-based health content and the responsible use of AI in medical writing.

I am a practicing clinical pharmacist with over 20 years of experience and a graduate of St. John’s University School of Pharmacy in Queens, NY. With an undergraduate background in compounding and natural medicine, I have served in various capacities across the pharmaceutical industry before founding Fusion Medical Care in Scottsdale, AZ. My career is defined by my dedication to a balanced approach between natural and allopathic medicine, a passion that led me to develop a complete wellness center housing multiple integrative practitioners. Beyond my foundational education, I have advanced my specialized training through the Professional Compounding Centers of America and am a Certified Diplomate of the American Board of Anti-Aging Health Practitioners. I believe that my role as a pharmacist offers the perfect opportunity to fuse naturopathic and allopathic care, acting as a dedicated advocate for my patients' pharmacological and wellness needs. My mission is to empower patients to look and feel amazing by following my core philosophy: "Let your food be your medicine, your kitchen be your pharmacy, and your lifestyle be your doctor". My innovative approach to healthcare has earned me national recognition, including an honor in Marquis Who’s Who and a featured interview with VoyagePhoenix highlighting my journey and the mission behind Fusion Medical Care.

Vincent Caradec is the French CEO and Co-Founder of Healthi Life (healthi-life.com), Bangkok's Urban Longevity House — a physician-led longevity, preventive and regenerative medicine clinic serving 50+ nationalities. Available for expert commentary on: - Building a longevity clinic in Asia - Medical tourism market trends in Thailand and Southeast Asia - CEO insights on preventive medicine adoption - GLP-1 weight management market (Tirzepatide, Retatrutide, Mounjaro, Wegovy) - Stem cell, exosome and NAD+ regenerative therapies - 300+ biomarker testing programs and longevity diagnostics - Wellness industry business strategy and pricing - Asian healthcare entrepreneurship Healthi Life operates an integrated longevity center offering check-ups, 3-12 month longevity programs, corporate wellness contracts and advanced regenerative therapies (stem cells, exosomes, NAD+, peptides, IV therapy). French national based in Bangkok. Fluent in English and French. Available for interviews on Zoom, Google Meet, WhatsApp.

Ryan Farmer is the founder of My Peptide Match, a consumer education site that helps people make sense of GLP-1 medications and the fast-changing peptide landscape. He focuses on simplifying complex topics—like real-world pricing, treatment pathways, sourcing differences, and what questions to ask—so readers can make more informed decisions with their clinician. Ryan tracks emerging trends across weight-loss peptides, compounding and telehealth access, and the economics that shape what consumers actually pay. He’s available to comment on GLP-1 and peptide cost comparisons, patient decision-making, and the broader market shifts driving demand. He also publishes practical reference tools, including a peptide calculator and dosage guide, to support clearer conversations between consumers and providers.

Emanuele Andreano is an immunologist and biotech innovator redefining how vaccines are discovered for pandemic threats. As Head of Serology and Immunology at the Fondazione Biotecnopolo di Siena and a leader in the European Vaccine Hub, he works at the intersection of AI, immunology, and global health. He pioneered Reverse Vaccinology 3.0, a breakthrough approach that can identify entirely new vaccine targets in days instead of years. In a first-of-its-kind demonstration, his team showed that artificial intelligence can predict unknown viral antigens directly from human antibody sequences—effectively reversing the traditional vaccine discovery process. His work spans monoclonal antibody discovery and next-generation vaccines against emerging pathogens, including mpox and SARS-CoV-2, with direct implications for global pandemic preparedness and biosecurity. Andreano has received international recognition, including the Antonio Feltrinelli Prize from the Accademia Nazionale dei Lincei, awarded in the presence of the President of the Italian Republic Sergio Mattarella, the IUIS Rising Star in Immunology, and a European Research Council (ERC) grant. He also co-directs a vaccinology program at the Institut Pasteur in Paris. “We are entering an era where vaccines can be discovered at unprecedented speed—transforming our ability to fight pandemics and save countless lives.”

Dr. Robert Abraham is a regenerative medicine consultant and healthcare strategy advisor with more than a decade of experience operating multi-location healthcare practices. He earned his Bachelor of Science in Health Sciences and Biology from the University of Central Florida before pursuing advanced training in clinical operations and regenerative-focused program development. Based in Florida, Dr. Abraham has worked with healthcare organizations throughout the Orlando region and nationwide, advising clinics on structured implementation, operational systems design, revenue forecasting, and compliance-conscious growth within regenerative medicine and wound care services. In addition to his consulting work, he serves as Chief Executive Officer of Cross Biotech, a biologics distribution company supporting providers in aligning product access with disciplined operational frameworks. His work emphasizes infrastructure-driven expansion, leadership accountability, and sustainable healthcare systems.

Vardan Ter-Antonyan is a pharmaceutical research and development executive with more than 20 years of experience advancing products from concept through commercialization. His expertise spans drug formulation, pharmaceutical development, manufacturing scale-up, quality systems, regulatory strategy, and commercialization across pharmaceuticals, medical devices, nutraceuticals, cannabinoids, and medical technologies. Throughout his career, Vardan has led multidisciplinary R&D teams, developed novel drug delivery systems, optimized manufacturing processes, and helped organizations bring innovative products to market while navigating complex regulatory requirements. His technical expertise includes lipid-based drug delivery systems, nanoemulsions, self-emulsifying drug delivery systems (SEDDS/SNEDDS), liposomes, controlled-release technologies, and formulation development for poorly water-soluble compounds. In addition to his scientific leadership, Vardan is passionate about bridging the gap between research and commercial success. He regularly advises companies on product development strategy, technology commercialization, operational excellence, and innovation management. His work combines deep scientific knowledge with practical business insight, enabling organizations to accelerate development timelines, improve product quality, and reduce technical risk. Vardan is also an author, speaker, and industry thought leader who enjoys sharing evidence-based perspectives on pharmaceutical innovation, drug delivery, biotechnology, diagnostics, manufacturing, and executive leadership. He welcomes opportunities to provide expert commentary for journalists covering advances in pharmaceutical science, healthcare innovation, biotechnology, regulatory affairs, and emerging medical technologies.

Dr. Bruce Dorr is boarded in Obstetrics and Gynecology and subspecialty boarded in Urogynecology and Reconstructive Pelvic Surgery as well as fully certified with the Institute for Functional Medicine. He also serves as senior medical advisor for Biote. For the last two decades he has directed his practice towards a functional medicine practice of hormone health and wellness and became IFM certified in 2025. Dr. Dorr joined Littleton GYN & Wellness in 1997. He enjoys using his teaching skills in the private practice setting to educate his patients about various aspects of their health. He is a member of the American Urogynecology Society, the Menopause Society and the Sexual Medicine Society of North America. As a Platinum Educator and Key Opinion Leader, he’s delivered over 70 national physician training programs and led physician training for major clinical trials, including Mirena Phase III, the Yaz PMDD and acne studies, and the IoGen molecular iodine trial. Dr. Dorr has held several leadership roles at Littleton Adventist Hospital, including Chairman of the OB/GYN Department and founder/co-chair of the Robotics Committee. He served as a Da Vinci Surgical Proctor and Educator and currently holds a role as an InMode Key Opinion Leader and Faculty Speaker. He has also been honored to hold an appointment as Assistant Professor of Obstetrics and Gynecology at Denver Health Medical Center/University of Colorado School of Medicine. He has worked as a locum tenens physician across underserved areas throughout the country and with the Indian Health Service in Chinle, Arizona, and led surgical Mission trips with Centura Global Health Initiatives in Nepal and Peru. Dr. Dorr held several positions at AdventHealth Hospital including Chairman of the OB/GYN Department, Director of Pelvic Floor Services, Chairman of the Peer Review Committee and member of the Credentialing Committee. He was also a reviewer for the Colorado Medical Board.

Founder of MDx CRO a specialized clinical research and regulatory consultancy dedicated to the medtech IVD sector. As a seasoned consultant in clinical and regulatory affairs, I am experienced in navigating complex regulatory challenges for top IVD companies. I have the privilege of serving as an external expert for the EU Commission and having lead global regulatory projects at BSI, one of the largest Notified Bodies as an IVDR CE mark technical expert. My portfolio of satisfied clients includes renowned companies such as Biomerieux, Cepheid, Leica (Danaher), Hologic, Grifols, Abbott, Beckman Coulter, ThermoFisher Scientific, Instrumentation Laboratory (Werfen), Roche Diagnostics, Alere, and more. I am passionate about simplifying science and regulation for my clients, delivering tailored solutions that help them stay ahead of the competition. My secret to success is building relationships based on trust, expertise and kindness. My clinical background, combined with 15+ years in the IVD industry and regulatory authorities, makes me a valuable resource for clients of all sizes. Let's connect and find out how I can help you navigate the ever-evolving world of IVD and MedTech 💬

I edit Europe Pharma Today — a Europe-first news desk covering EMA and CHMP decisions, EU HTA, and national market-access moves for industry professionals. We focus on what changed, what it means for access, and what to watch next — with clear sourcing, not noise.

Shane Hellmrich holds a BSc in Health Promotion and has spent the past 11 years independently testing and reviewing online modafinil vendors — placing personal test orders, verifying product authenticity, and documenting shipping reliability across dozens of suppliers. His work at BuyModa.net tracks over 1,300 verified customer transactions and maintains a public testing methodology that has become a trusted reference point for consumers navigating the grey-market pharmaceutical space. Shane's research covers vendor reliability scoring, product authentication, shipping logistics across international jurisdictions, and the pharmacokinetic profiles of generic modafinil products. He is regularly consulted on topics including nootropics and cognitive enhancement, online pharmacy safety and regulation, pharmaceutical sourcing and supply chain transparency, consumer protection in unregulated markets, and the real-world usage patterns of prescription cognitive enhancers. Shane is available for expert commentary, background briefings, and on-the-record quotes for journalists covering health, productivity, pharmacology, biohacking, and consumer safety.

ABAAHP Diplomate and founder of Evidence Based Longevity (evidencebasedlongevity.co), a free clinical evidence platform that grades supplements exclusively by human randomized controlled trial data. The platform maps 137 medication-nutrient depletions across 50+ drug classes, provides NNT/NNH context for 11 medication categories, and includes interactive tools for stack auditing, biomarker-tracked dose optimization, and deprescribing support — all cited to 130+ PubMed references. Areas of expertise: evidence-based supplement grading, medication-nutrient interactions, deprescribing frameworks, longevity biomarker optimization, NNT/absolute risk transparency, polypharmacy and nutrient depletion, functional medicine evidence standards, consumer health technology. Available to comment on: supplement safety and efficacy, medication side effects and nutrient depletions, the gap between relative and absolute risk in prescribing, evidence standards in longevity medicine, and how patients can prepare for informed conversations with their physicians.

Dr. Manthan Tripathi is a medical professional, healthcare writer, and digital health educator based in India, with a clinical foundation from Atal Bihari Vajpayee Medical University, Lucknow. He combines frontline medical training with over 3,000 published articles across patient education, preventive medicine, medical technology, and AI in healthcare, making him one of India's most prolific evidence-based health communicators. His work has appeared on platforms including Medicircle, HospitalSuggest, HealthVoice, DocVo, Dr. Malpani and IVF Matters, and is recognized for translating complex clinical concepts into accurate, reader-friendly content that helps patients make genuinely informed decisions. His healthcare and education content has generated over 55 million cumulative views across digital platforms. Dr. Tripathi brings a perspective that is rare among health sources: deep India-specific clinical knowledge, including India's disease burden, government health schemes, Indian drug brand names, and regional dietary patterns; context that generic Western health content consistently misses. He is the founder of drmanthan.com, an evidence-based health information and clinical tools platform built specifically for Indian patients, families, and medical students. He has also worked as a Subject Matter Expert with Physics Wallah and Chegg India, contributing academic content for competitive medical examinations including NEET. His areas of expertise include internal medicine, thyroid and metabolic disorders, diabetes, preventive health, and India-specific patient education. Journalists covering Indian healthcare, global health disparities, patient literacy, medical misinformation, or AI in medicine will find in Dr. Tripathi a source who speaks with both clinical accuracy and genuine public communication experience.

*Board-Certified Family Medicine Physician (ABFM) with 14+ years clinical experience (based in Chicago, IL) *Named Castle Connolly Top Doctor (2024, 2025) *Medical Media Commentator seen on/in ABC 7, Fox 32, CBS 2, WGN 9, The Chicago Tribune , Chicago Sun Times, and Everyday Health; including a nationwide 25 interview satellite media tour (TV & radio, November 2025) *Premedical Student Mentor, Urban Bridges Medical Mentoring Program Dr. Rene is a board-certified Family Medicine physician and Fellow of the American Academy of Family Physicians (FAAFP) with 14+ years of clinical experience. She provides comprehensive primary care for Medicare-eligible patients at Oak Street Health's Avalon Park location in Chicago, specializing in chronic disease management, preventive care, healthcare equity, and access for underserved communities. After overcoming 50 medical school rejections, Dr. Rene graduated from Indiana University School of Medicine and completed residency training at Ascension Saint Joseph Hospital - Chicago. She developed the L.Y.M.I.T.S. Method—a framework for transforming limitations into your greatest strengths. She mentors aspiring physicians through the Urban Bridges Medical Mentoring Program. Dr. Rene has appeared as a medical expert on ABC 7, Fox 32, CBS 2, and WGN 9 Chicago and recently completed a 25-interview national satellite media tour. She is available for expert commentary on resilience in healthcare, medical education equity, resilience and overcoming failure, healthcare access for underserved populations, and diversity in medicine.

I am the Founder and CEO of RCR|HUB, a U.S.-based platform that connects healthcare organizations with their Revenue Cycle partners (vendors) through education, awareness, and collaboration in healthcare revenue cycle management. I have more than 20 years of experience in healthcare marketing and technology, with a particular focus on Revenue Cycle Management strategies, AI-powered visibility, SEO/GEO, vendor positioning, automation, and the adoption of healthcare technology. Through my work with RCR|HUB, I provide solutions to help your organization improve discoverability, industry awareness, and connectivity.

With a PhD in molecular genetics and as a specialist in data science, Céline Chantry-Darmon has over twenty years of experience in biomedical research and complex data analysis. As Scientific Director at Tekkare, she works on developing trustworthy artificial intelligence for healthcare. She is also committed to promoting inclusive and responsible artificial intelligence, and to advancing women in science and technology.

I am an MD-PhD physician-scientist with a passion for translating complex clinical and scientific data into clear, accurate content. My training and experience span clinical practice and translational research, with expertise across oncology, immunology, gastroenterology, inflammation & metabolism, and rare diseases. With over 10 years of experience, I have supported key deliverables including more than 30 peer-reviewed publications, manuscripts, slide decks, literature reviews, and scientific narratives. I enjoy working in collaborative, deadline-driven environments and am particularly interested in medical writing, medical information, and publication development, where scientific accuracy and effective storytelling intersect.

Dr. Yoon Hang “John” Kim is a board-certified integrative medicine physician with over 20 years of clinical experience dedicated to root-cause, patient-centered care. He is widely recognized as one of the leading clinical experts on Low-Dose Naltrexone (LDN) therapy, having authored three books and more than 20 articles on the subject, and leads the LDN Support Group—a thriving community of over 7,000 members. Dr. Kim completed his Integrative Medicine Fellowship at the University of Arizona’s Andrew Weil Center for Integrative Medicine, where he trained under the mentorship of Dr. Andrew Weil as a prestigious Osher Fellow. He holds board certifications in both Preventive Medicine and Integrative/Holistic Medicine, along with certification in Medical Acupuncture from UCLA. He was also a scholarship recipient from the Institute for Functional Medicine (IFM), further deepening his expertise in functional medicine approaches to complex chronic conditions. His clinical expertise spans integrative oncology—informed by deeply personal experience supporting family members who are now cancer survivors—chronic pain management, and the treatment of complex conditions including SIBO, MCAS, and autoimmune disorders. He brings a unique combination of conventional medical rigor and evidence-based complementary therapies to every patient encounter. Dr. Kim is the founder of Direct Integrative Care, a membership-based telemedicine practice that deliberately limits enrollment to ensure deep, personalized physician-patient relationships. His practice serves patients across six states—Iowa, Illinois, Missouri, Texas, Georgia, and Florida—operating entirely outside the constraints of insurance systems to preserve clinical independence and patient-first decision-making. A featured speaker at the LDN Research Trust conferences, Dr. Kim is a passionate educator who shares his expertise through his clinical and professional websites, a YouTube channel, and educational platforms including LDNSupportGroup.com. His personal motto—“Luck favors the prepared bold”—reflects his commitment to courage, preparation, and innovation in medicine.

Helping patients access groundbreaking therapies through licensed physicians, not the grey market. Michael N. Zachman is the Founder and CEO of Madison Meds, a family-owned telehealth platform based in Boca Raton, Florida. He launched Madison Meds in 2025 to pair fair pricing with concierge-level service, connecting eligible patients with an independent network of US-licensed providers and compounding pharmacies for compounded GLP-1 medications, peptide therapies, hair health, and longevity-focused care. Michael speaks to operations, pricing, regulatory access, and patient demand in modern telehealth, with a focus on why family-run brands compete differently from venture-backed ones.